Why Atomo?
Consumers are embracing the power of at-home diagnostics and telehealth. We believe that fast, accurate point of care testing empowers people to enjoy healthier, more informed lives.
Our Story
After ten years as a senior leader in the medical device sector, Atomo’s Founder and CEO John Kelly identified multiple ways in which diagnostics were ripe for transformation. John observed that usability, convenience, and simplicity of use could make a real difference in diagnostics. When people can’t use a product the way it is intended, the performance is undermined.
While John was exploring areas of the market where usability was poorly delivered, his youngest daughter was born and required intensive medical care for the first two years of her life. He watched as doctors struggled to collect blood from her arm. When John found out that the blood test they were doing only required a tiny drop of blood, he had a light bulb moment. John decided to develop a better, less invasive way to collect a blood sample.
The Opportunity
This is a crucial time for healthcare. The growing consumer acceptance of telemedicine has revolutionised how healthcare is delivered, enabling patients to access medical care from the comfort of their homes. This shift has been driven by advancements in technology, increased internet accessibility, and a desire for more convenient and immediate healthcare solutions.
Patients and healthcare providers alike now expect real-time access to diagnostic information, which is critical for timely decision-making and effective treatment planning. This expectation has significantly increased the demand for rapid point-of-care diagnostics.
Point-of-care diagnostics offer the advantage of immediate results, which can be crucial in managing acute conditions, monitoring chronic diseases, and conducting routine health assessments. These diagnostics are particularly valuable in remote or underserved areas where access to traditional laboratory facilities is limited. The ability to conduct tests and obtain results quickly on-site enhances the overall efficiency of healthcare delivery and improves patient outcomes.
Vision & Mission
Values
Impact
Commercialising products that matter to our users
Innovation
Fostering creative thinking and solutions
Integrity
Ensuring honesty and fairness in all that we do
Collaboration
Working as one
global team
Excellence
Being recognised as experts in the field
Executive Team
John Kelly
Founder, Managing Director & CEO
For more than 20 years John Kelly has championed the cause of reimagining medical devices to enhance their usability and performance. Before founding Atomo Diagnostics in 2010, John was Chief Operating Officer at ASX listed (now NASDAQ listed) Unilife Corporation, where he led the ‘Unifill’ development team to develop the world’s first glass prefilled drug delivery device with integrated auto retract safety feature. This technology was successfully licensed to Sanofi Aventis. Previously, John led the New Product Implementation Group at ResMed, where he managed the design and commercialisation of the ground-breaking Mirage Swift mask. In addition to his commercial experience, John has an Honours Degree in Mechanical Engineering from the University of Liverpool, a Master’s Degree in Systems Engineering from Queen’s University Belfast, and an Executive MBA from the University of Sydney, where he was awarded the Business School’s inaugural ‘Excellence in Leadership’ scholarship.
Chandra Sukumar
Chief Operating Officer
Chandra joined Atomo in 2017 as Director of Programs bringing with her more than 25 years of experience within the medical device industry. She has extensive experience in the development of medical devices from conception to commercialisation. Prior to joining Atomo, she served in a variety of leadership roles within ResMed, including supply chain management, global manufacturing, and APAC marketing. Chandra holds a Bachelors Honours degree in Physics and an executive MBA from AGSM.
Board of Directors
Dr. Cheri Walker
Non-Executive Director
Dr. Walker is an executive with more than twenty-five years of experience working with life science and diagnostic companies. Employing years in the financial markets as a stock analyst, commercial execution to meet aggressive growth targets, and more than 45 successfully closed mergers, acquisitions and divestitures, she has worked as part of and with management teams, private equity and venture firms to develop the best strategies to build their life science business and to execute on acquisition strategies or sale of the company. Dr. Walker is currently the CEO of Zeta Corporation and has previously served as President, Chief Executive Officer, and Director of Rhinostics, an early-stage spin-out company based on technology initially developed at Harvard University. She has also held senior executive positions at Abcam; Charles River Labs; Qiagen, and Life Technologies, now part of ThermoFisher. Dr. Walker holds a BA in Biology from Swarthmore College and a Ph.D. in Human and Molecular Genetics from Baylor College.
Patrick Cook
Non-Executive Director
An experienced Non-Executive Director and Chair with over 35 years experience as a senior executive in medical devices & point-of-care diagnostics sectors within various multinational, private and listed biotechnology companies. Currently serves as Non-Executive Director at Workplace Drug Testing Australasia Ltd and as a Committee Member at Animal Ethics Committee QUT. Previously served as Non-Executive Director & Chair at eWaste Connection Ltd, Board Member at Prostate Cancer Foundation of Australia (Qld), a Fellow of the Australian Institute of Company Directors and holds degrees in Science and Marketing.
Anthony May
Non-Executive Director
Mr May has held various Director roles across international corporations including Hoechst Germany, Microgenics Corporation USA, Fisher Scientific and Thermo Fisher Scientific. With extensive experience across public and private pathology laboratories, as well as sales and management roles in the IVD supply sector, he has built a strong track record in business leadership and strategic growth. Mr May is a member of the Australasian Association for Clinical Biochemistry and Laboratory Medicine and holds a bachelor’s degree in science.
Work With Us
Atomo is a fast-growing dynamic company with tremendous opportunities for people interested in revolutionising healthcare through rapid point-of-care diagnostics.
We’re looking for energetic, creative, entrepreneurial people who have a keen interest in using technology to make the world a better place.
